𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytomegalovirus (CMV) prophylaxis and infection in pediatric heart transplant recipients

✍ Scribed by K.R Kanter; D.C Naftel; E Pahl; C.E Canter; S.A Webber; R.N Vincent; J.K Kirklin; W.R Morrow

Book ID
116517887
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
78 KB
Volume
23
Category
Article
ISSN
1557-3117

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au